43 results
Page 2 of 3
6-K
EX-1.1
5r510r
5 Mar 20
Report of Foreign Private Issuer
8:16am
424B5
l0t2qv0f3nagjc78i
3 Mar 20
Prospectus supplement for primary offering
5:13pm
6-K
EX-1.1
4u3p3r
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
424B5
kwg0 gxjr6lq9ni
26 Feb 20
Prospectus supplement for primary offering
8:23am
20-F/A
7oym5ybgrcd 0a4
23 Jan 20
Annual report (foreign) (amended)
4:31pm
424B5
tp16g
20 Nov 19
Prospectus supplement for primary offering
4:46pm
F-3
9fkigaje
7 Jun 19
Shelf registration (foreign)
3:31pm
6-K
EX-99.3
8iw09wbeadn4swytfi
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
EX-99.4
h8gtqiwl mo4
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
EX-99.2
dvtvvw p8g
6 Dec 18
Amended Notice of Annual and Extraordinary General Meeting of the Shareholders
4:43pm
6-K
EX-99.1
zb5l5ecm73e
19 Nov 18
Agreement and Plan of Merger
4:34pm
6-K
EX-99.2
i81r5fp189f
19 Nov 18
Agreement and Plan of Merger
4:34pm
20-F
7pwtajyq8c4nnmqj
31 Mar 15
Annual report (foreign)
12:00am